Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Luna Carrillo-Alemán
Effectiveness and Safety of Direct Oral Anticoagulants Compared With Vitamin K Antagonists in Non-Valvular Atrial Fibrillation Patients Undergoing Electrical Cardioversion
Journal of Clinical Trials in Cardiology
Related publications
Patients With Non-Valvular Atrial Fibrillation on Vitamin K Antagonists or Direct-Acting Oral Anticoagulants: Patients Profile and Long-Term Follow-Up Outcomes
Archivos de cardiolog�a de M�xico (English ed. Internet)
Novel Anticoagulants Versus Vitamin K Antagonists for Cardioversion of Non- Valvular Atrial Fibrillation – A Meta-Analysis of More Than 17000 Patients
Scientific Reports
Multidisciplinary
Impact of Non-Vitamin K Antagonist Oral Anticoagulants on Intracranial Bleeding in Asian Patients With Non-Valvular Atrial Fibrillation
Circulation Journal
Medicine
Cardiovascular Medicine
Cardiology
Effectiveness and Safety of 110 or 150 Mg Dabigatran Versus Vitamin K Antagonists in Non-Valvular Atrial Fibrillation.
British Journal of Clinical Pharmacology
Pharmacology
Comparative Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants and Warfarin in Patients With Atrial Fibrillation: Propensity Weighted Nationwide Cohort Study
British Medical Journal
Medicine
Overview of the Non-Vitamin K Oral Anticoagulants for Atrial Fibrillation
Therapeutic Advances in Cardiovascular Disease
Cardiovascular Medicine
Pharmacology
Cardiology
Comparison Between Long-Term Clinical Outcomes of Vitamin K Antagonist and Direct Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
Circulation Journal
Medicine
Cardiovascular Medicine
Cardiology
Effect and Risk of Novel Oral Anticoagulants Versus Warfarin in Patients With Non-Valvular Atrial Fibrillation
Journal of Cardiology
Cardiovascular Medicine
Cardiology
Safety and Efficacy of Direct Oral Anticoagulants for Atrial Fibrillation in Patients With Renal Impairment
Pharmacy